Nazanin Falconer

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Venues

British journal of clinical pharmacology

Journal of medical systems

European journal of clinical pharmacology

Drugs & aging

University of Queensland

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Queensland Apr 05 2016

Australia

Ph.D. Candidate :: Pharmacy Australia Center for Excellence

Publications

Sreyon Murthi, Nataly Dominica Martini, Nazanin Falconer, Shane L Scahil
Evaluating EHR-Integrated Digital Technologies for Medication-Related Outcomes and Health Equity in Hospitalised Adults: A Scoping Review. Journal of medical systems 48 (1) (2024)
Sreyon Murthi, Nataly Dominica Martini, Nazanin Falconer, Shane L Scahil
Evaluating EHR-Integrated Digital Technologies for Medication-Related Outcomes and Health Equity in Hospitalised Adults: A Scoping Review. Journal of medical systems 48 (1) (2024)
Sreyon Murthi, Nataly Dominica Martini, Nazanin Falconer, Shane L Scahil
Evaluating EHR-Integrated Digital Technologies for Medication-Related Outcomes and Health Equity in Hospitalised Adults: A Scoping Review. Journal of medical systems 48 (1) (2024)
Nazanin Falconer, Michael Barras, Ahmad Abdel-Hafiz, Sam Radburn, Neil Cottrell
Evaluation of two European risk models for predicting medication harm in an Australian patient cohort. European journal of clinical pharmacology 78 (4) (2022)
Nazanin Falconer, David L Paterson, Nancye Peel, Alyssa Welch, Christopher Freeman, Ellen Burkett, Ruth Hubbard, Tracy Comans, Leila Shafiee Hanjani, Elaine Pascoe, Carmel Hawley, Leonard Gray
A multimodal intervention to optimise antimicrobial use in residential aged care facilities (ENGAGEMENT): protocol for a stepped-wedge cluster randomised trial. Trials 23 (1) (2022)
Ahmad Abdel-Hafez, Ian A Scott, Nazanin Falconer, Stephen Canaris, Oscar Bonilla, Sven Marxen, Aaron Van Garderen, Michael A Barras
Predicting Therapeutic Response to Unfractionated Heparin Therapy: Machine Learning Approach. Interactive journal of medical research 11 (2) (2022)
Jonathan Yong Jie Lam, Michael A Barras, Ian A Scott, Duncan Long, Leila Shafiee Hanjani, Nazanin Falconer
Scoping Review of Studies Evaluating Frailty and Its Association with Medication Harm. Drugs & aging 39 (5) (2022)
Nazanin Falconer, Ahmad Abdel-Hafez, Ian A Scott, Sven Marxen, Stephen Canaris, Michael Barras
Systematic review of machine learning models for personalised dosing of heparin. British journal of clinical pharmacology 87 (11) (2021)
Nazanin Falconer, Anne Spinewine, Matthew P Doogue, Michael Barras
Identifying medication harm in hospitalised patients: a bimodal, targeted approach. Therapeutic advances in drug safety 11 (2020)
Nazanin Falconer, Michael Barras, Ahmad Abdel-Hafez, Sam Radburn, Neil Cottrell
Development and validation of the Adverse Inpatient Medication Event model (AIME). British journal of clinical pharmacology 87 (3) (2020)
Nazanin Falconer, Michael Barras, Neil Cottrell
Reply to Iuga and Genaidy 'Comment on Falconer et al. (2018) - the need for specific adverse drug reaction outcomes'. British journal of clinical pharmacology 84 (8) (2018)
Nazanin Falconer, Michael A Barras, Neil W Cottrell
Systematic review of predictive risk models for adverse drug events in hospitalized patients. British journal of clinical pharmacology 84 (5) (2018)
Nazanin Falconer, Michael Barras, Jennifer Martin, Neil Cottrell
Defining and classifying terminology for medication harm: a call for consensus. European journal of clinical pharmacology 75 (2) (2018)

Nazanin Falconer.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nazanin Falconer